A novel mouse model of in-stent restenosis


      Background and aims

      In-stent restenosis (ISR) is the major complication that occurs after percutaneous coronary interventions to facilitate coronary revascularization. Herein we described a simple and cost-effective model, which reproduces important features of ISR in the mouse.

      Methods and results

      Microvascular bare metal stents were successfully implanted in the abdominal aorta of atherosclerotic ApoE-null mice. Patency of implanted stents was interrogated using ultrasound biomicroscopy. Aortas were harvested at different time points after implantation and processed for histopathological analysis. Thrombus formation was histologically detected after 1 day. Leukocyte adherence and infiltration were evident after 7 days and decreased thereafter. Neointimal formation, neointimal thickness and luminal stenosis simultaneously increased up to 28 days after stent implantation. Using multichannel fluorescence molecular tomography (FMT) for spatiotemporal resolution of MMP activities, we observed that MMP activity in the stented aorta of Apo-E null mice was 2-fold higher than that of wild-type mice. Finally, we compared neointimal formation in response to stenting in two genetically different mouse strains. In-stent neointimas in FVB/NJ mice were 2-fold thicker than in C57BL/6J mice (p = 0.002).


      We have developed a model that can take advantage of the multiple genetic resources available for the mouse to study the mechanisms of in-stent restenosis.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Atherosclerosis
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Lowe H.C.
        • Oesterle S.N.
        • Khachigian L.M.
        Coronary in-stent restenosis: current status and future strategies.
        J Am Coll Cardiol. 2002; 39: 183-193
        • Geary R.L.
        • Clowes A.W.
        Epidemiology and pathogenesis of restenosis.
        in: Duckers H.D. Nabel E.G. Serruys P.W. Essentials of restenosis. Humana Press, New Jersey2007
        • Al Suwaidi J.
        • Berger P.B.
        • Holmes Jr., D.R.
        Coronary artery stents.
        JAMA. 2000; 284: 1828-1836
        • Mitra A.K.
        • Agrawal D.K.
        In stent restenosis: bane of the stent era.
        J Clin Pathol. 2006; 59: 232-239
        • Welt F.G.P.
        • Rogers C.
        Inflammation and restenosis in the stent era.
        Arterioscler Thromb Vasc Biol. 2002; 22: 1769-1776
        • Gershlick A.H.
        • Baron J.
        Dealing with in-stent restenosis.
        Heart. 1998; 79: 319-323
        • Deux J.-F.
        • Meddahi-Pelle A.
        • Le Blanche A.F.
        • et al.
        Low molecular weight fucoidan prevents neointimal hyperplasia in rabbit iliac artery in-stent restenosis model.
        Arterioscler Thromb Vasc Biol. 2002; 22: 1604-1609
        • Rogers C.
        • Edelman E.R.
        Endovascular stent design dictates experimental restenosis and thrombosis.
        Circulation. 1995; 91: 2995-3001
        • Schwartz R.S.
        • Edwards W.D.
        • Bailey K.R.
        • et al.
        Differential neointimal response to coronary artery injury in pigs and dogs. Implications for restenosis models.
        Arterioscler Thromb. 1994; 14: 395-400
        • Lowe H.C.
        • Schwartz R.S.
        • Mac Neill B.D.
        • et al.
        The porcine coronary model of in-stent restenosis: current status in the era of drug-eluting stents.
        Catheter Cardiovasc Interv. 2003; 60: 515-523
        • Schwartz R.S.
        • Huber K.C.
        • Murphy J.G.
        • et al.
        Restenosis and the proportional neointimal response to coronary artery injury: results in a porcine model.
        J Am Coll Cardiol. 1992; 19: 267-274
        • Lowe H.C.
        • James B.
        • Khachigian L.M.
        A novel model of in-stent restenosis: rat aortic stenting.
        Heart. 2005; 91: 393-395
        • Roks A.J.
        • Henning R.H.
        • van Boven A.J.
        • Tio R.A.
        • van Gilst W.H.
        Rat abdominal aortic stenting: a simple model displaying in-stent restenosis.
        Am J Cardiol. 2002; 89: 1149-1150
        • Schwartz R.S.
        • Chronos N.A.
        • Virmani R.
        Preclinical restenosis models and drug-eluting stents: still important, still much to learn.
        J Am Coll Cardiol. 2004; 44: 1373-1385
        • Peters L.L.
        • Robledo R.F.
        • Bult C.J.
        • et al.
        The mouse as a model for human biology: a resource guide for complex trait analysis.
        Nat Rev Genet. 2007; 8: 58-69
        • Wouters K.
        • Shiri-Sverdlov R.
        • van Gorp P.J.
        • van Bilsen M.
        • Hofker M.H.
        Understanding hyperlipidemia and atherosclerosis: lessons from genetically modified apoe and ldlr mice.
        Clin Chem Lab Med. 2005; 43: 470-479
        • Breslow J.L.
        Mouse models of atherosclerosis.
        Science. 1996; 272: 685-688
        • Fazio S.
        • Linton M.F.
        Mouse models of hyperlipidemia and atherosclerosis.
        Front Biosci. 2001; 6: D515-525
        • Ali Z.A.
        • Alp N.J.
        • Lupton H.
        • et al.
        Increased in-stent stenosis in ApoE knockout mice: insights from a novel mouse model of balloon angioplasty and stenting.
        Arterioscler Thromb Vasc Biol. 2007; 27: 833-840
        • Rippstein P.
        • Black M.K.
        • Boivin M.
        • et al.
        Comparison of processing and sectioning methodologies for arteries containing metallic stents.
        J Histochem Cytochem. 2006; 54: 673-681
        • Kornowski R.
        • Hong M.K.
        • Tio F.O.
        • et al.
        In-stent restenosis: contributions of inflammatory responses and arterial injury to neointimal hyperplasia.
        J Am Coll Cardiol. 1998; 31: 224-230
        • Ntziachristos V.
        Fluorescence molecular imaging.
        Annu Rev Biomed Eng. 2006; 8: 1-33
        • Chomczynski P.
        • Mackey K.
        Short technical report. Modification of the TRIZOL reagent procedure for isolation of RNA from Polysaccharide-and proteoglycan-rich sources.
        Biotechniques. 1995; 19: 942-945
        • Livak K.J.
        • Schmittgen T.D.
        Analysis of relative gene expression data using real-time quantitative PCR and the 2-[Delta][Delta]CT.
        Methods. 2001; 25: 402-408
        • Jones G.T.
        • Kay I.P.
        • Chu J.W.S.
        • et al.
        Elevated plasma active matrix metalloproteinase-9 level is associated with coronary artery in-stent restenosis.
        Arterioscler Thromb Vasc Biol. 2006; 26: e121-125
        • Ge J.
        • Shen C.
        • Liang C.
        • et al.
        Elevated matrix metalloproteinase expression after stent implantation is associated with restenosis.
        Int J Cardiol. 2006; 112: 85-90
        • Feldman L.J.
        • Mazighi M.
        • Scheuble A.
        • et al.
        Differential expression of matrix metalloproteinases after stent implantation and balloon angioplasty in the hypercholesterolemic rabbit.
        Circulation. 2001; 103: 3117-3122
        • MacNeill B.D.
        • Lowe H.C.
        • Takano M.
        • Fuster V.
        • Jang I.-K.
        Intravascular modalities for detection of vulnerable plaque: current status.
        Arterioscler Thromb Vasc Biol. 2003; 23: 1333-1342
        • Fayad Z.A.
        • Fuster V.
        Clinical imaging of the high-risk or vulnerable atherosclerotic plaque.
        Circ Res. 2001; 89: 305-316
        • Escolar E.
        • Weigold G.
        • Fuisz A.
        • Weissman N.J.
        New imaging techniques for diagnosing coronary artery disease.
        Can Med Assoc J. 2006; 174: 487-495
        • Deguchi J.-O.
        • Aikawa M.
        • Tung C.-H.
        • et al.
        Inflammation in atherosclerosis: visualizing matrix metalloproteinase action in macrophages in vivo.
        Circulation. 2006; 114: 55-62
        • Smith J.
        Quantitative trait locus mapping for atherosclerosis susceptibility.
        Curr Opin Lipidol. 2003; 14: 499-504
        • Harmon K.J.
        • Couper L.L.
        • Lindner V.
        Strain-dependent vascular remodeling phenotypes in inbred mice.
        Am J Pathol. 2000; 156: 1741-1748